Product Code: GVR-1-68038-251-8
Optical Coherence Tomography Market Growth & Trends:
The global optical coherence tomography market size is expected to reach USD 5.28 billion by 2030, registering a CAGR of 15.57% during the forecast period, according to a new report by Grand View Research, Inc.. Rising demand for early diagnosis of the disease, constant innovation and development of newer technologies, higher demand from the new biomedical applications, such as drug delivery, and rising prevalence of eye disorders are expected to drive the Optical Coherence Tomography (OCT) industry growth. However, the lack of favorable reimbursement policies and clinical information can hamper the growth in the coming years.The technique has numerous uses in fields like dermatology, cancer, and ophthalmology.
It is largely used to diagnose and treat disorders affecting the eyes, including glaucoma, conditions affecting the retina, such as central serous retinopathy, Age-related Macular Degeneration (AMD), and vitreous traction. An additional definition of the market includes new technology for high-resolution cross-sectional imaging. It takes a picture with micrometer-resolution using coherent light. Other illnesses like non-melanoma prostate cancer, skin cancer, esophageal issues, cardiovascular disruptions, and diabetes have been added to the market's reach. A significant increase in demand for the product is anticipated due to the rising incidence of these diseases.
The COVID-19 pandemic has led to a huge surge in demand for medical supplies and respiratory support devices, such as life-support machines, atomizers, oxygen generators, and monitors. OCT angiography is used for the imaging of retinal vascular changes in fully-recovered COVID-19 patients. The key manufacturers of OCT systems are struggling to maintain their production capacity, along with finding newer methods to strengthen their presence, such as mergers & acquisitions and collaborations with suitable market players. These initiatives by key players can be positive for the industry's growth in the coming years.
Optical Coherence Tomography Market Report Highlights:
- The Frequency Domain OCT (FD-OCT) segment accounted for the largest revenue share in 2022 followed by Time Domain OCT (TD-OCT)
- The handheld OCT devices segment held the largest share in 2022 and will expand further at a steady CAGR from 2023 to 2030
- The growth can be attributed to a wide application scope in the detection of diabetic retinopathy, macular degeneration, and glaucoma
- Ophthalmology is the dominant application segment owing to increasing incidences of choroidal & retinal disorders and the high adoption of OCT devices by ophthalmologists for imaging & diagnosing purposes
- North America dominated the global industry in 2022 and held the largest share of the overall revenue
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Technology
- 1.1.2. Type
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology outlook
- 2.2.2. Type outlook
- 2.2.3. Application outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Optical Coherence Tomography Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Optical Coherence Tomography Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Optical Coherence Tomography: Technology Estimates & Trend Analysis
- 4.1. Optical Coherence Tomography Market: Key Takeaways
- 4.2. Optical Coherence Tomography Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Time Domain
- 4.3.1. Time domain market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Frequency Domain
- 4.4.1. Frequency domain market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Spatial Encoded Frequency Domain
- 4.5.1. Spatial encoded frequency domain market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.1.1. Fourier domain
- 4.5.1.1.1. Fourier domain market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.1.2. Others
- 4.5.1.2.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Optical Coherence Tomography: Type Estimates & Trend Analysis
- 5.1. Optical Coherence Tomography Market: Key Takeaways
- 5.2. Optical Coherence Tomography Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Catheter-based Devices
- 5.3.1. Catheter-based devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Doppler Devices
- 5.4.1. Doppler devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Handheld Devices
- 5.5.1. Handheld devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Tabletop Devices
- 5.6.1. Tabletop devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Optical Coherence Tomography: Application Estimates & Trend Analysis
- 6.1. Optical Coherence Tomography Market: Key Takeaways
- 6.2. Optical Coherence Tomography Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Ophthalmology
- 6.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Cardiovascular
- 6.4.1. Cardiovascular market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Oncology
- 6.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Dermatology
- 6.6.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Optical Coherence Tomography Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Optical Coherence Tomography Market by Region: Key Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. Agfa - Gevaert Group
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product Benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Carl Zeiss Meditec AG
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Heidelberg Engineering GmbH
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Imalux Corp
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Michelson Diagnostics
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Novacam Technologies Inc.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. OPTOPOL Technology S.A.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Metall Zug AG
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Topcon Corporation
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Thorlabs Inc.
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. Abbott.
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives